SCHEMBL29806232

SCHEMBL29806232

Nc1ncnc2c1ccn2[C@H]1O[C@H]([C@H](O)c2ccc(Cl)c(F)c2)[C@@H](O)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 1.00
▸ WDR77 Q9BQA1 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21391701 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18026294 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL21413929 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL30382155 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18026039 0.92 PRMT5 (0.85) PRMT5WDR77
SCHEMBL18026086 0.92 PRMT5 (0.85) PRMT5WDR77
SCHEMBL21413926 0.92 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18009773 0.92 PRMT5 (1.00) PRMT5WDR77
SCHEMBL18205031 0.92 PRMT5 (1.00) PRMT5WDR77
SCHEMBL19696639 0.92 PRMT5 (1.00) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022153161-A1 TREATMENT OF CANCER USING A PRMT5 INHIBITOR PFIZER INC. (US) 2022-07-21 — — WO claimed
WO-2022153161-A1 TREATMENT OF CANCER USING A PRMT5 INHIBITOR PFIZER INC. (US) 2022-07-21 — — WO disclosed
Send feedback